pCI-neo-hCG Citations (3)

Originally described in: Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin.
Shih IM, Torrance C, Sokoll LJ, Chan DW, Kinzler KW, Vogelstein B Nat Med. 2000 Jun . 6(6):711-4. PubMed Journal

---

Articles Citing pCI-neo-hCG

Articles
BRCA1 regulation on beta-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer. Sengodan SK, Nadhan R, Nair RS, Hemalatha SK, Somasundaram V, Sushama RR, Rajan A, Latha NR, Varghese GR, Thankappan RK, Kumar JM, Chil A, Anilkumar TV, Srinivas P. Oncogenesis. 2017 Sep 4;6(9):e376. doi: 10.1038/oncsis.2017.75. PubMed
Proteomic Profiling of beta-hCG-Induced Spheres in BRCA1 Defective Triple Negative Breast Cancer Cells. Sengodan SK, Rajan A, Hemalatha SK, Nadhan R, Jaleel A, Srinivas P. J Proteome Res. 2018 Jan 5;17(1):276-289. doi: 10.1021/acs.jproteome.7b00562. Epub 2017 Nov 7. PubMed
betahCG mediates immune suppression through upregulation of CD11b(+) Gr1(+) myeloid derived suppressor cells, CD206(+) M2 macrophages, and CD4(+) FOXP3(+) regulatory T-cells in BRCA1 deficient breast cancers. Varghese GR, Patra D, Jaikumar VS, Rajan A, Latha NR, Srinivas P. Immunology. 2023 Jun 20. doi: 10.1111/imm.13673. PubMed

If you have published an article using this material, please email us at to have your article added to this page.